Capstone Asset Management’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$375K Sell
9,499
-960
-9% -$39.4K 0.01% 1096
2017
Q1
$424K Sell
10,459
-1,610
-13% -$62.9K 0.01% 1024
2016
Q4
$485K Sell
12,069
-3,430
-22% -$129K 0.01% 956
2016
Q3
$561K Sell
15,499
-160
-1% -$5.49K 0.02% 875
2016
Q2
$454K Buy
15,659
+390
+3% +$11.8K 0.01% 986
2016
Q1
$534K Sell
15,269
-650
-4% -$21K 0.02% 887
2015
Q4
$513K Buy
15,919
+100
+0.6% +$3.24K 0.01% 903
2015
Q3
$511K Buy
15,819
+750
+5% +$28.2K 0.02% 904
2015
Q2
$623K Sell
15,069
-7,910
-34% -$333K 0.02% 812
2015
Q1
$1.03M Buy
22,979
+800
+4% +$33.4K 0.03% 649
2014
Q4
$830K Sell
22,179
-2,700
-11% -$98.9K 0.02% 730
2014
Q3
$869K Sell
24,879
-40
-0.2% -$1.43K 0.03% 650
2014
Q2
$879K Buy
24,919
+3,261
+15% +$109K 0.03% 679
2014
Q1
$706K Sell
21,658
-1,050
-5% -$40.1K 0.02% 805
2013
Q4
$957K Sell
22,708
-5,871
-21% -$242K 0.03% 669
2013
Q3
$1.14M Buy
28,579
+710
+3% +$29.8K 0.03% 688
2013
Q2
$1.15M Buy
+27,869
New +$1.13M 0.03% 635

Other funds holding HAE

Capstone Asset Management's HAE Position: Q2 2017 in Review

Capstone Asset Management reduced its Haemonetics (HAE) stake by 9.2% in Q2 2017, selling an estimated $39.4K and leaving 9,499 shares worth $375K. The position accounts for 0.01% of the portfolio, ranked #1096.

Capstone Asset Management first reported a position in HAE in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.15M in Q2 2013. 197 funds tracked by Wall St. Rank hold HAE as of Q2 2017.

  • Capstone Asset Management held 9,499 shares of Haemonetics worth $375K as of Q2 2017.
  • Capstone Asset Management sold 960 Haemonetics shares in Q2 2017, an estimated $39.4K.
  • Haemonetics made up 0.01% of Capstone Asset Management's portfolio in Q2 2017, its #1096 holding.
  • Capstone Asset Management first reported a position in Haemonetics in Q2 2013 and has held it in 17 quarters since.
  • Capstone Asset Management's Haemonetics position peaked at $1.15M in Q2 2013.
  • 197 funds tracked by Wall St. Rank held Haemonetics as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.